Compare CGTX & MRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGTX | MRDN |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.6M | 83.7M |
| IPO Year | 2021 | 2008 |
| Metric | CGTX | MRDN |
|---|---|---|
| Price | $0.99 | $13.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 394.7K | 67.3K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.79 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $182,863,373.00 |
| Revenue This Year | N/A | $16.30 |
| Revenue Next Year | N/A | $12.32 |
| P/E Ratio | ★ N/A | $74.89 |
| Revenue Growth | N/A | ★ 21.01 |
| 52 Week Low | $0.55 | $6.01 |
| 52 Week High | $2.26 | $16.09 |
| Indicator | CGTX | MRDN |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 44.54 |
| Support Level | $0.93 | $13.17 |
| Resistance Level | $1.18 | $14.95 |
| Average True Range (ATR) | 0.05 | 0.65 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 43.03 | 19.35 |
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).
Meridian Holdings Inc is engaged in the online gaming and betting business, providing sports betting, online casino, and gaming operations across multiple jurisdictions in Europe, Africa, and Central and South America. The company has three reportable segments: MeridianBet Group, GMAG, and RKings & CFAC. The MeridianBet Group segment includes retail and online sports betting, casinos, and related gaming operations. The GMAG segment focuses on the resale of third-party gaming content, mainly serving customers in the Asia-Pacific region. The RKings & CFAC segment is involved in pay-to-enter prize competitions and trade promotions conducted in the United Kingdom and Australia. It generates the majority of its revenue from the MeridianBet Group segment.